Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 18, 2009 - Issue 4
Submit an article Journal homepage
761
Views
64
CrossRef citations to date
0
Altmetric
Reviews

IKur/Kv1.5 channel blockers for the treatment of atrial fibrillation

Juan Tamargo Universidad Complutense, School of Medicine, Department of Pharmacology, 28040 Madrid, Spain +34 91 3941472; +34 91 3941470; [email protected]
,
Ricardo Caballero Universidad Complutense, School of Medicine, Department of Pharmacology, 28040 Madrid, Spain +34 91 3941472; +34 91 3941470; [email protected]
,
Ricardo Gómez Universidad Complutense, School of Medicine, Department of Pharmacology, 28040 Madrid, Spain +34 91 3941472; +34 91 3941470; [email protected]
&
Eva Delpón Universidad Complutense, School of Medicine, Department of Pharmacology, 28040 Madrid, Spain +34 91 3941472; +34 91 3941470; [email protected]
Pages 399-416 | Published online: 01 Apr 2009

Citations (64)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Lingyue Zhao, Qian Yang, Yiqun Tang, Qidong You & Xiaoke Guo. (2022) Design, synthesis, and biological evaluation of arylmethylpiperidines as Kv1.5 potassium channel inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 462-471.
Read now
William Nguyen. (2013) Novel Kv1.3 blockers for immunosuppression: WO2012155199. Expert Opinion on Therapeutic Patents 23:11, pages 1511-1516.
Read now
Noel W. Gray, Boris S. Zhorov & Edward G. Moczydlowski. (2013) Interaction of local anesthetics with the K+ channel pore domain. Channels 7:3, pages 182-193.
Read now
Carina Blomström-Lundqvist & Per Blomström. (2012) Safety and efficacy of pharmacological cardioversion of atrial fibrillation using intravenous vernakalant, a new antiarrhythmic drug with atrial selectivity. Expert Opinion on Drug Safety 11:4, pages 671-679.
Read now
Neil A Castle. (2010) Pharmacological modulation of voltage-gated potassium channels as a therapeutic strategy. Expert Opinion on Therapeutic Patents 20:11, pages 1471-1503.
Read now
Andrew Tinker & Stephen C Harmer. (2010) K+ channels in the heart: new insights and therapeutic implications. Expert Review of Clinical Pharmacology 3:3, pages 305-319.
Read now

Articles from other publishers (58)

Moza M. Al-Owais, Nishani T. Hettiarachchi, Mark L. Dallas, Jason L. Scragg, Jonathan D. Lippiat, Arun V. Holden, Derek S. Steele & Chris Peers. (2023) Inhibition of the voltage-gated potassium channel Kv1.5 by hydrogen sulfide attenuates remodeling through S-nitrosylation-mediated signaling. Communications Biology 6:1.
Crossref
Monika Richter-Laskowska, Paulina Trybek, Domenico Vittorio Delfino & Agata Wawrzkiewicz-Jałowiecka. (2023) Flavonoids as Modulators of Potassium Channels. International Journal of Molecular Sciences 24:2, pages 1311.
Crossref
T. Crespo-García, A. Cámara-Checa, M. Dago, M. Rubio-Alarcón, J. Rapún, J. Tamargo, E. Delpón & R. Caballero. (2022) Regulation of cardiac ion channels by transcription factors: Looking for new opportunities of druggable targets for the treatment of arrhythmias. Biochemical Pharmacology 204, pages 115206.
Crossref
Chunxuan Wu, Jianhua Yan & Wei Li. (2022) Acacetin as a Potential Protective Compound against Cardiovascular Diseases. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-6.
Crossref
Wei Qin, Yi-Heng Li, Jing Tong, Jie Wu, Dong Zhao, Hui-Jin Li, Lu Xing, Chun-Xia He, Xin Zhou, Peng-Quan Li, Ge Meng, Shao-Ping Wu & Hui-Ling Cao. (2022) Rational Design and Synthesis of 3-Morpholine Linked Aromatic-Imino-1H-Indoles as Novel Kv1.5 Channel Inhibitors Sharing Vasodilation Effects. Frontiers in Molecular Biosciences 8.
Crossref
Samuel Lévy. (2021) Cardioversion of recent‐onset atrial fibrillation using intravenous antiarrhythmics: A European perspective. Journal of Cardiovascular Electrophysiology 32:12, pages 3259-3269.
Crossref
Aya M. Emam, Steve Peigneur, Anne-Sophie Depuydt, Samy M. Ibrahim, Ernesto Lopes Pinheiro-Junior, Mohamed El-Sadek, Louise Hendrickx, Jan Tytgat & Hend Kothayer. (2021) Quinazolinone dimers as a potential new class of safer Kv1 inhibitors: Overcoming hERG, sodium and calcium channel affinities. Bioorganic Chemistry 115, pages 105264.
Crossref
Arvin H. Soepriatna, Tae Yun Kim, Mark C. Daley, Elena Song, Bum-Rak Choi & Kareen L. K. Coulombe. (2021) Human Atrial Cardiac Microtissues for Chamber-Specific Arrhythmic Risk Assessment. Cellular and Molecular Bioengineering 14:5, pages 441-457.
Crossref
Attila Oláh, Bálint András Barta, Alex Ali Sayour, Mihály Ruppert, Eszter Virág-Tulassay, Julianna Novák, Zoltán V. Varga, Péter Ferdinandy, Béla Merkely & Tamás Radovits. (2021) Balanced Intense Exercise Training Induces Atrial Oxidative Stress Counterbalanced by the Antioxidant System and Atrial Hypertrophy That Is Not Associated with Pathological Remodeling or Arrhythmogenicity. Antioxidants 10:3, pages 452.
Crossref
Zhen WangSrinivas Tapa, Samantha D. Francis Stuart, Lianguo Wang, Julie BossuytBrian P. Delisle & Crystal M. Ripplinger. (2020) Aging Disrupts Normal Time-of-Day Variation in Cardiac Electrophysiology. Circulation: Arrhythmia and Electrophysiology 13:9.
Crossref
Mark A. Munger, Yusuf Olğar, Megan L. Koleske, Heather L. Struckman, Jessica Mandrioli, Qing Lou, Ingrid Bonila, Kibum Kim, Roberto Ramos Mondragon, Silvia G. Priori, Pompeo Volpe, Héctor H. Valdivia, Joseph Biskupiak, Cynthia A. Carnes, Rengasayee Veeraraghavan, Sándor Györke & Przemysław B. Radwański. (2020) Tetrodotoxin‐Sensitive Neuronal‐Type Na + Channels: A Novel and Druggable Target for Prevention of Atrial Fibrillation . Journal of the American Heart Association 9:11.
Crossref
F Fusi, A Trezza, M Tramaglino, G Sgaragli, S Saponara & O Spiga. (2020) The beneficial health effects of flavonoids on the cardiovascular system: Focus on K+ channels. Pharmacological Research 152, pages 104625.
Crossref
Zefeng Zhao, Songsong Ruan, Xiaoming Ma, Qian Feng, Zhuosong Xie, Zhuang Nie, Peinan Fan, Mingcheng Qian, Xirui He, Shaoping Wu, Yongmin Zhang & Xiaohui Zheng. (2019) Challenges Faced with Small Molecular Modulators of Potassium Current Channel Isoform Kv1.5. Biomolecules 10:1, pages 10.
Crossref
Lu Fu, Fang Rao, Feihong Lian, Hui Yang, Sujuan Kuang, Shulin Wu, Chunyu Deng & Yumei Xue. (2019) Mechanism of electrical remodeling of atrial myocytes and its influence on susceptibility to atrial fibrillation in diabetic rats. Life Sciences 239, pages 116903.
Crossref
Ting-Ting Fan, Hui-Hui Zhang, Yang-Hua Tang, Fan-Zhong Zhang & Bing-Nan Han. (2019) Two New Neo-debromoaplysiatoxins—A Pair of Stereoisomers Exhibiting Potent Kv1.5 Ion Channel Inhibition Activities. Marine Drugs 17:12, pages 652.
Crossref
Li GengShuo WangFulei ZhangKe XiongJian HuangTingting ZhaoDan ShiFei LvLi LiDandan LiangYingyu CuiYi LiuDuanyang XieYi-Han Chen. (2019) SNX17 (Sorting Nexin 17) Mediates Atrial Fibrillation Onset Through Endocytic Trafficking of the Kv1.5 (Potassium Voltage-Gated Channel Subfamily A Member 5) Channel. Circulation: Arrhythmia and Electrophysiology 12:4.
Crossref
A John Camm, Paul Dorian, Stefan H Hohnloser, Peter R Kowey, Benoît Tyl, Yongbin Ni, Victoria Vandzhura, Pierre Maison-Blanche, Mirko de Melis & Prashanthan Sanders. (2019) A randomized, double-blind, placebo-controlled trial assessing the efficacy of S66913 in patients with paroxysmal atrial fibrillation. European Heart Journal - Cardiovascular Pharmacotherapy 5:1, pages 21-28.
Crossref
Akiko Kojima, Yutaka Fukushima, Yuki Ito, Wei-Guang Ding, Rika Ueda, Tomoyoshi Seto, Hirotoshi Kitagawa & Hiroshi Matsuura. (2018) Interactions of Propofol With Human Voltage-gated Kv1.5 Channel Determined by Docking Simulation and Mutagenesis Analyses. Journal of Cardiovascular Pharmacology 71:1, pages 10-18.
Crossref
Juan Tamargo & Eva Delpón. 2018. Cardiac Electrophysiology: From Cell to Bedside. Cardiac Electrophysiology: From Cell to Bedside 513 524 .
Haibo Ni, Dominic G. Whittaker, Wei Wang, Wayne R. Giles, Sanjiv M. Narayan & Henggui Zhang. (2017) Synergistic Anti-arrhythmic Effects in Human Atria with Combined Use of Sodium Blockers and Acacetin. Frontiers in Physiology 8.
Crossref
Nace Zidar, Aleš Žula, Tihomir Tomašič, Marc Rogers, Robert W. Kirby, Jan Tytgat, Steve Peigneur, Danijel Kikelj, Janez Ilaš & Lucija Peterlin Mašič. (2017) Clathrodin, hymenidin and oroidin, and their synthetic analogues as inhibitors of the voltage-gated potassium channels. European Journal of Medicinal Chemistry 139, pages 232-241.
Crossref
Michael A. Colman, Haibo Ni, Bo Liang, Nicole Schmitt & Henggui Zhang. (2017) In silico assessment of genetic variation in KCNA5 reveals multiple mechanisms of human atrial arrhythmogenesis. PLOS Computational Biology 13:6, pages e1005587.
Crossref
Prashantha Gunaga, John Lloyd, Somanadham Mummadi, Abhisek Banerjee, Naveen Kumar Dhondi, James Hennan, Veena Subray, Ramya Jayaram, Nagendra Rajugowda, Kommuri Umamaheshwar Reddy, Duraimurugan Kumaraguru, Umasankar Mandal, Dasthagiri Beldona, Ashok Kumar Adisechen, Navnath Yadav, Jayakumar Warrier, James A. Johnson, Harinath Sale, Siva Prasad Putlur, Ajay Saxena, Anjaneya Chimalakonda, Sandhya Mandlekar, MaryLee Conder, Dezhi Xing, Arun Kumar Gupta, Anuradha Gupta, Richard Rampulla, Arvind Mathur, Paul Levesque, Ruth R. Wexler & Heather J. Finlay. (2017) Selective I Kur Inhibitors for the Potential Treatment of Atrial Fibrillation: Optimization of the Phenyl Quinazoline Series Leading to Clinical Candidate 5-[5-Phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamide . Journal of Medicinal Chemistry 60:9, pages 3795-3803.
Crossref
Baode Yang, Chenxing Li, Junyi Sun, Xinghui Wang, Xinling Liu, Chun Yang, Lina Chen, Jun Zhou & Hao Hu. (2017) Inhibition of potassium currents is involved in antiarrhythmic effect of moderate ethanol on atrial fibrillation. Toxicology and Applied Pharmacology 322, pages 89-96.
Crossref
Guo-Sheng Xiao, Yan-Hui Zhang, Wei Wu, Hai-Ying Sun, Yan Wang & Gui-Rong Li. (2017) Genistein and tyrphostin AG556 decrease ultra-rapidly activating delayed rectifier K + current of human atria by inhibiting EGF receptor tyrosine kinase . British Journal of Pharmacology 174:6, pages 454-467.
Crossref
Akiko Kojima, Jia-Yu Bai, Yuki Ito, Wei-Guang Ding, Hirotoshi Kitagawa & Hiroshi Matsuura. (2016) Serum albumin attenuates the open-channel blocking effects of propofol on the human Kv1.5 channel. European Journal of Pharmacology 783, pages 117-126.
Crossref
Jamshed Warsi, Bernat Elvira, Rosi Bissinger, Zohreh Hosseinzadeh & Florian Lang. (2015) Regulation of Voltage-Gated K+ Channel Kv1.5 by the Janus Kinase JAK3. The Journal of Membrane Biology 248:6, pages 1061-1070.
Crossref
Akiko Kojima, Yuki Ito, Wei-Guang Ding, Hirotoshi Kitagawa & Hiroshi Matsuura. (2015) Interaction of propofol with voltage-gated human Kv1.5 channel through specific amino acids within the pore region. European Journal of Pharmacology 764, pages 622-632.
Crossref
Bernat Elvira, Jamshed Warsi, Carlos Munoz & Florian Lang. (2014) SPAK and OSR1 Sensitivity of Voltage-Gated K+ Channel Kv1.5. The Journal of Membrane Biology 248:1, pages 59-66.
Crossref
Jing Yu, Mi-Hyeong Park & Su-Hyun Jo. (2015) Inhibitory effects of cortisone and hydrocortisone on human Kv1.5 channel currents. European Journal of Pharmacology 746, pages 158-166.
Crossref
Seahyoung Lee, Eunhyun Choi, Min-Ji Cha & Ki-Chul Hwang. (2014) Looking into a Conceptual Framework of ROS–miRNA–Atrial Fibrillation. International Journal of Molecular Sciences 15:12, pages 21754-21776.
Crossref
Erich Wettwer & Heinrich Terlau. (2014) Pharmacology of voltage-gated potassium channel Kv1.5—impact on cardiac excitability. Current Opinion in Pharmacology 15, pages 115-121.
Crossref
Simone Loose, Judith Mueller, Erich Wettwer, Michael Knaut, John Ford, James Milnes & Ursula Ravens. (2014) Effects of IKur blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation. Frontiers in Pharmacology 5.
Crossref
Roine I. Olsson, Ingemar Jacobson, Tommy Iliefski, Jonas Boström, Öjvind Davidsson, Ola Fjellström, Annika Björe, Christina Olsson, Johan Sundell, Ulrik Gran, Jonna Gyll, Jesper Malmberg, Olle Hidestål, Hans Emtenäs, Tor Svensson, Zhong-Qing Yuan, Gert Strandlund, Annika Åstrand, Emma Lindhardt, Gunilla Linhardt, Elin Forsström, Ågot Högberg, Frida Persson, Birgit Andersson, Anna Rönnborg & Boel Löfberg. (2014) Lactam sulfonamides as potent inhibitors of the Kv1.5 potassium ion channel. Bioorganic & Medicinal Chemistry Letters 24:5, pages 1269-1273.
Crossref
Istvan Baczko, David Liknes, Wei Yang, Kevin C Hamming, Gavin Searle, Kristian Jaeger, Zoltan Husti, Viktor Juhasz, Gergely Klausz, Robert Pap, Laszlo Saghy, Andras Varro, Vernon Dolinsky, Shaohua Wang, Vivek Rauniyar, Dennis Hall, Jason RB Dyck & Peter E Light. (2014) Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillation. British Journal of Pharmacology 171:1, pages 92-106.
Crossref
Juan Tamargo & Eva Delpón. 2014. Cardiac Electrophysiology: From Cell to Bedside. Cardiac Electrophysiology: From Cell to Bedside 529 540 .
Heather Finlay. 2014. 101 113 .
Hannah E. BoycottCamille S. M. BarbierCatherine A. EichelKevin D. Costa, Raphael P. MartinsFlorent LouaultGilles DilanianAlain CoulombeStéphane N. Hatem & Elise Balse. (2013) Shear stress triggers insertion of voltage-gated potassium channels from intracellular compartments in atrial myocytes. Proceedings of the National Academy of Sciences 110:41.
Crossref
Ursula Ravens, Claire Poulet, Erich Wettwer & Michael Knaut. (2013) Atrial selectivity of antiarrhythmic drugs. The Journal of Physiology 591:17, pages 4087-4097.
Crossref
Ingemar Jacobson, Göran Duker, Malin Florentzson, Gunilla Linhardt, Emma Lindhardt, Ann-Kristin Nordkam, Annika Åstrand & Leif Carlsson. (2013) Electrophysiological Characterization and Antiarrhythmic Efficacy of the Mixed Potassium Channel-Blocking Antiarrhythmic Agent AZ13395438 In Vitro and In Vivo. Journal of Cardiovascular Pharmacology and Therapeutics 18:3, pages 290-300.
Crossref
Roine I. Olsson, Ingemar Jacobson, Jonas Boström, Tomas Fex, Annika Björe, Christina Olsson, Johan Sundell, Ulrik Gran, Anna Öhrn, Andreas Nordin, Jonna Gyll, Maria Thorstensson, Ahlke Hayen, Karolina Aplander, Olle Hidestål, Fanyi Jiang, Gunilla Linhardt, Elin Forsström, Teresa Collins, Monika Sundqvist, Emma Lindhardt, Annika Åstrand & Boel Löfberg. (2013) Synthesis and evaluation of diphenylphosphinic amides and diphenylphosphine oxides as inhibitors of Kv1.5. Bioorganic & Medicinal Chemistry Letters 23:3, pages 706-710.
Crossref
Yi Liu, Xiao-Hui Xu, Zheng Liu, Xin-Ling Du, Kui-Hao Chen, Xin Xin, Zhen-Dong Jin, Ji-Zhong Shen, Yan Hu, Gui-Rong Li & Man-Wen Jin. (2012) Effects of the natural flavone trimethylapigenin on cardiac potassium currents. Biochemical Pharmacology 84:4, pages 498-506.
Crossref
Imju Jeong, Bok Hee Choi, Shin Hee Yoon & Sang June Hahn. (2012) Carvedilol blocks the cloned cardiac Kv1.5 channels in a β-adrenergic receptor-independent manner. Biochemical Pharmacology 83:4, pages 497-505.
Crossref
Sobuj Mia, Carlos Munoz, Tatsiana Pakladok, Gulab Siraskar, Jakob Voelkl, Ioana Alesutan & Florian Lang. (2012) Downregulation of Kv1.5 K + Channels by the AMP-Activated Protein Kinase . Cellular Physiology and Biochemistry 30:4, pages 1039-1050.
Crossref
Carlos Munoz, Roberta H. Tóvolli, Mentor Sopjani, Ioana Alesutan, Rebecca S. Lam, Guiscard Seebohm, Michael Föller & Florian Lang. (2012) Activation of voltage gated K+ channel Kv1.5 by β-catenin. Biochemical and Biophysical Research Communications 417:2, pages 692-696.
Crossref
Hui-Jun Wu, Wei Wu, Hai-Ying Sun, Guo-Wei Qin, Hong-Bing Wang, Panwen Wang, Hari Krishna Yalamanchili, Junwen Wang, Hung-Fat Tse, Chu-Pak Lau, Paul M. Vanhoutte & Gui-Rong Li. (2011) Acacetin causes a frequency- and use-dependent blockade of hKv1.5 channels by binding to the S6 domain. Journal of Molecular and Cellular Cardiology 51:6, pages 966-973.
Crossref
Sony Jacob, Omaima A Ali, Victoria Pidlaoan, Apurva O Badheka & Nicholas Z Kerin. (2011) Pharmacotherapy of Atrial Fibrillation: A Pathophysiological Perspective and Review. American Journal of Therapeutics 18:3, pages 241-260.
Crossref
U. Ravens & E. Wettwer. (2010) Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications. Cardiovascular Research 89:4, pages 776-785.
Crossref
Curt D. Haffner, Stephen A. Thomson, Yu Guo, Lee T. Schaller, Sharon Boggs, Scott Dickerson, Jeff Gobel, Dan Gillie & J. Patrick Condreay. (2010) N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 inhibitors. Part 1. Bioorganic & Medicinal Chemistry Letters 20:23, pages 6983-6988.
Crossref
Curt D. Haffner, Stephen A. Thomson, Yu Guo, Kimberly Petrov, Andrew Larkin, Pierette Banker, Gregory Schaaf, Scott Dickerson, Jeff Gobel, Dan Gillie, J. Patrick Condreay, Chuck Poole, Tiffany Carpenter & John Ulrich. (2010) Substituted N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 ion channel blockers. Part 2. Bioorganic & Medicinal Chemistry Letters 20:23, pages 6989-6992.
Crossref
Joachim Almquist, Mikael Wallman, Ingemar Jacobson & Mats Jirstrand. (2010) Modeling the Effect of Kv1.5 Block on the Canine Action Potential. Biophysical Journal 99:9, pages 2726-2736.
Crossref
Leif Carlsson, Göran Duker & Ingemar Jacobson. (2010) New pharmacological targets and treatments for atrial fibrillation. Trends in Pharmacological Sciences 31:8, pages 364-371.
Crossref
Douglas C. Beshore, Nigel J. Liverton, Charles J. McIntyre, Christopher F. Claiborne, Brian Libby, J. Christopher Culberson, Joseph J. Salata, Christopher P. Regan, Joseph J. Lynch, Laszlo Kiss, Robert H. Spencer, Stephanie A. Kane, Rebecca B. White, Suzie Yeh, George D. Hartman & Christopher J. Dinsmore. (2010) Discovery of triarylethanolamine inhibitors of the Kv1.5 potassium channel. Bioorganic & Medicinal Chemistry Letters 20:8, pages 2493-2496.
Crossref
Adriana Barana, Irene Amorós, Ricardo Caballero, Ricardo Gómez, Lourdes Osuna, M. Pilar Lillo, Cristina Blázquez, Manuel Guzmán, Eva Delpón & Juan Tamargo. (2010) Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner. Cardiovascular Research 85:1, pages 56-67.
Crossref
Gui-Rong Li & Ming-Qing Dong. 2010. Cardiovascular Pharmacology - Heart and Circulation. Cardiovascular Pharmacology - Heart and Circulation 93 134 .
Heike Wulff, Neil A. Castle & Luis A. Pardo. (2009) Voltage-gated potassium channels as therapeutic targets. Nature Reviews Drug Discovery 8:12, pages 982-1001.
Crossref
Michael Hentrich. (2015) Artificial Neural Command Theory. SSRN Electronic Journal.
Crossref
Michael Hentrich. (2014) Curing Cancer: Binary Solutions. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.